Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Immunol Immunopathol ; 136(1-2): 157-62, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20347491

ABSTRACT

Programmed death 1 (PD-1) is a member of the immunoglobulin (Ig) superfamily, which is expressed on activated T cells, B cells and monocytes. Many researches have demonstrated that a high level of PD-1 expression is closely related to persistent infection and immune evasion in some human infections. In order to study the relationship between PD-1 expression and persistent infections caused by some porcine viruses, we first cloned the porcine PD-1 from porcine PBMCs based on the blast result in the EST database using the human PD-1 sequence. Sequence analysis showed that the cloned PD-1 molecule shares 63 and 54% amino acid sequence identity with human and murine PD-1, respectively. Its molecular structure is also similar to that of human and murine PD-1, containing an IgV-like domain in the extracellular region and two immune regulatory motifs in its cytoplasmic tail. The in vitro T cell proliferation assay showed that the cloned PD-1 could inhibit porcine T cell proliferation by 71% and secretion of IFN-gamma and IL-2 by 64 and 53%, respectively. These data suggest that porcine PD-1 negatively regulates the porcine immune response in a similar manner to that of its counterpart in the human and mouse immune system.


Subject(s)
Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/immunology , Sus scrofa/genetics , Sus scrofa/immunology , Amino Acid Sequence , Animals , Antigens, CD/genetics , Antigens, Surface/genetics , Base Sequence , Cell Proliferation , Cloning, Molecular , Conserved Sequence , DNA Primers/genetics , Humans , Immunoglobulins/genetics , In Vitro Techniques , Lymphocyte Activation , Mice , Molecular Sequence Data , Programmed Cell Death 1 Receptor , Sequence Homology, Amino Acid , T-Lymphocytes/cytology , T-Lymphocytes/immunology
2.
Clin Immunol ; 125(3): 337-45, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17900990

ABSTRACT

HBcAg18-27 (FLPSDFFPSV, V27 epitope) is a dominant HLA-A2-restricted epitope in hepatitis B virus (HBV)-infected patients. So far, the occurrence of the epitope has not been assessed in China, where the prevalence of chronic HBV infection is high. In this report, we sequenced the HBV core gene in 105 Chinese patients with chronic HBV infection. Approximately 93.3% (98/105) of the core genes that were sequenced contained mutations with amino acid substitution at position 27 of the core protein: a mutation from a valine to an isoleucine (V27I). The mutant peptide (FLPSDFFPSI, I27) was found to bind to the HLA-A2 molecule with high affinity and elicit specific cytotoxic T lymphocyte (CTL) responses in acutely infected hepatitis B patients. In CTL assays using I27-specific pentamer staining, the V27 epitope showed a cross-reactive T cell response specific for the I27 epitope, but not vice versa. These findings provide important insights for the design of HBcAg18-27-based vaccines in the future.


Subject(s)
Epitopes, T-Lymphocyte/genetics , Hepatitis B Core Antigens/genetics , Hepatitis B virus/genetics , Hepatitis B, Chronic/genetics , T-Lymphocytes, Cytotoxic/immunology , Amino Acid Sequence , China , Cross Reactions , Epitopes, T-Lymphocyte/immunology , Flow Cytometry , HLA-A2 Antigen/chemistry , HLA-A2 Antigen/immunology , HLA-A2 Antigen/metabolism , Hepatitis B Core Antigens/chemistry , Hepatitis B Core Antigens/immunology , Hepatitis B virus/immunology , Hepatitis B, Chronic/immunology , Humans , Molecular Sequence Data , Mutation , Polymerase Chain Reaction , Prevalence , Protein Structure, Secondary
SELECTION OF CITATIONS
SEARCH DETAIL
...